Mirone V, Imbimbo C, Palmieri A, Fuso F: Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Cipollone G, Nicolai M, Mastroprimiano G, Iantoro R, Longeri D, Tenaglia R: Betamethasone versus placebo in Peyronie's disease. Peyronie's disease patients with a curvature not exceeding 50 degrees with mild or no erectile dysfunction ED were eligible. The IIEF-EF domain scores were administered at baseline and at the end of study. Mean stretched and flaccid penile length increased by 1. Written by: Gontero P, Di Marco M, Giubilei G, Bartoletti R, Pappagallo G, Tizzani A, Mondaini N Reference: PubMed Abstract. Photographic pictures of the erect penis and measurements were carried out at baseline, at 1, 3, 6, and 12 months end of study. Treatment satisfaction was assessed at end of study using a nonvalidated institutional 5-item questionnaire. Bichler KH, Lahme S, Mattauch W, Petri E: Collagen metabolism in induratio penis plastica IPP. Patients were counselled on the use of the penile extender for at least 5 hours per day for 6 months. Changes in penile length over baseline and erectile function EF domain scores of the International Index of Erectile Function IIEF constituted secondary end points. To test this hypothesis in a Phase II study using a commonly marketed brand of penile extender. The selection of patients with a stabilized disease, a penile curvature not exceeding 50 degrees , and no severe ED may have led to outcomes underestimating the potential efficacy of the treatment. Results were maintained at 12 months. Overall treatment results were subjectively scored as acceptable in spite of curvature improvements, which varied from "no change" to "mild improvement. Results of a Phase II Prospective Study - Abstract "Klinische Studie als Nachweis zur erfolgreichen Behandlung zur Begradigung von Penisverkrümmungen ohne OP.。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。